Quo vadis artificial intelligence?

Y Jiang, X Li, H Luo, S Yin, O Kaynak - Discover Artificial Intelligence, 2022 - Springer
The study of artificial intelligence (AI) has been a continuous endeavor of scientists and
engineers for over 65 years. The simple contention is that human-created machines can do …

[HTML][HTML] Organ-on-a-chip meets artificial intelligence in drug evaluation

S Deng, C Li, J Cao, Z Cui, J Du, Z Fu, H Yang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Drug evaluation has always been an important area of research in the pharmaceutical
industry. However, animal welfare protection and other shortcomings of traditional drug …

Deep learning-based smart predictive evaluation for interactive multimedia-enabled smart healthcare

Z Lv, Z Yu, S Xie, A Alamri - ACM Transactions on Multimedia Computing …, 2022 - dl.acm.org
Two-dimensional arrays of bi-component structures made of cobalt and permalloy elliptical
dots with thickness of 25 nm, length 1 mm and width of 225 nm, have been prepared by a …

Deep learning analysis of vibrational spectra of bacterial lysate for rapid antimicrobial susceptibility testing

WJ Thrift, S Ronaghi, M Samad, H Wei, DG Nguyen… - ACS …, 2020 - ACS Publications
Rapid antimicrobial susceptibility testing (AST) is an integral tool to mitigate the unnecessary
use of powerful and broad-spectrum antibiotics that leads to the proliferation of multi-drug …

[HTML][HTML] Patient-specific organoid and organ-on-a-chip: 3D cell-culture meets 3D printing and numerical simulation

F Zheng, Y Xiao, H Liu, Y Fan, M Dao - Advanced biology, 2021 - ncbi.nlm.nih.gov
The last few decades have witnessed diversified in vitro models to recapitulate the
architecture and function of living organs or tissues and contribute immensely to advances in …

Applications of tumor chip technology

SJ Hachey, CCW Hughes - Lab on a Chip, 2018 - pubs.rsc.org
Over the past six decades the inflation-adjusted cost to bring a new drug to market has been
increasing constantly and doubles every 9 years–now reaching in excess of $2.5 billion …

A review of deep learning-based approaches for detection and diagnosis of diverse classes of drugs

A Kumar, N Kumar, J Kuriakose, Y Kumar - Archives of Computational …, 2023 - Springer
Artificial intelligence-based drug discovery has gained attention lately since it drastically cuts
the time and money needed to produce new treatments. In recent years, a vast quantity of …

Prediction of drug adverse events using deep learning in pharmaceutical discovery

CY Lee, YPP Chen - Briefings in Bioinformatics, 2021 - academic.oup.com
Traditional machine learning methods used to detect the side effects of drugs pose
significant challenges as feature engineering processes are labor-intensive, expert …

Net2vis–a visual grammar for automatically generating publication-tailored cnn architecture visualizations

A Bäuerle, C Van Onzenoodt… - IEEE transactions on …, 2021 - ieeexplore.ieee.org
To convey neural network architectures in publications, appropriate visualizations are of
great importance. While most current deep learning papers contain such visualizations …

Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches

B Güvenç Paltun, H Mamitsuka… - Briefings in …, 2021 - academic.oup.com
Predicting the response of cancer cell lines to specific drugs is one of the central problems in
personalized medicine, where the cell lines show diverse characteristics. Researchers have …